Rashtriya Chemicals & Fertilizers Fund Raise of ₹995 Cr

Rashtriya Chemicals & Fertilizers Other Announcement

Rashtriya Chemicals and Fertilizers Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI LODR regulations.

Rashtriya Chemicals & Fertilizers Credit Rating

CARE Ratings reaffirmed RCF's Commercial Paper rating at CARE A1+ for a Rs.3000 Crore facility. The reaffirmation reflects stable capital structure and strong government-backed liquidity.

Rashtriya Chemicals & Fertilizers Debt & Borrowing

Rashtriya Chemicals and Fertilizers disclosed details of its outstanding listed NCDs as of September 30, 2026, complying with SEBI's ISIN specifications for debt securities.

Rashtriya Chemicals & Fertilizers Annual General Meeting

RCF shareholders approved an amendment to the objects clause and a fundraise of up to ₹1,500 Crore via a Further Public Offering at the AGM.

Value

₹1,500 Cr

Rashtriya Chemicals & Fertilizers Capacity Expansion: ₹797 Cr Investment

RCF approved a ₹797 Crore order to L&T for revamping its Ammonia plant in Thal to enhance efficiency and reduce energy consumption.

Value

₹797.0 Cr

Execution

36 months

Rashtriya Chemicals & Fertilizers Management Change

Rashtriya Chemicals and Fertilizers Limited has appointed M/s. Raju & Prasad and M/s. J C R & Co, LLP as Statutory Auditors for a 12-month term.

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.

Gujarat Inject (Kerala) Fund Raise of ₹3 Cr

Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.

Value

₹3.00 Cr